Evidence map›Paper›PMID 32385840›Full record

ArticleDrug safety2020

Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions.

Ying Li, Antonio Jimeno Yepes, Cao Xiao

Open access · hybridAbstract read
In one paragraph

Article in Drug safety, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Pharmacovigilance in the digital age: gaining insight from social media data.Experimental biology and medicine (Maywood, N.J.) · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Engaging PatientsFrontiers in pharmacology · 2022
    Article
  15. Article
  16. [Utilizing social media data in post-market safety surveillance].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2021
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Ying LiCenter for Computational Health, IBM Thomas J. Watson Research Center, 1101 Kitchawan Rd, Yorktown Heights, NY, 10598, USA. liying@us.ibm.com.ORCID 0000-0002-2813-9480
Antonio Jimeno YepesIBM Research Australia, Melbourne, VIC, Australia.
Cao XiaoAnalytics Center of Excellence, IQVIA, Cambridge, MA, USA.
IBM Research - Australia · AUIBM (United States) · USIQVIA (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAdverse drug reactions (ADRs) are unintended reactions caused by a drug or combination of drugs taken by a patient. The current safety surveillance system relies on spontaneous reporting systems (SRSs) and more recently on observational health data; however, ADR detection may be delayed and lack geographic diversity. The broad scope of social media conversations, such as those on Twitter, can include health-related topics. Consequently, these data could be used to detect potentially novel ADRs with less latency. Although research regarding ADR detection using social media has made progress, findings are based on single information sources, and no study has yet integrated drug safety evidence from both an SRS and Twitter.

objectiveThe aim of this study was to combine signals from an SRS and Twitter to facilitate the detection of safety signals and compare the performance of the combined system with signals generated by individual data sources.

methodsWe extracted potential drug-ADR posts from Twitter, used Monte Carlo expectation maximization to generate drug safety signals from both the US FDA Adverse Event Reporting System and posts from Twitter, and then integrated these signals using a Bayesian hierarchical model. The results from the integrated system and two individual sources were evaluated using a reference standard derived from drug labels. Area under the receiver operating characteristics curve (AUC) was computed to measure performance.

resultsWe observed a significant improvement in the AUC of the combined system when comparing it with Twitter alone, and no improvement when comparing with the SRS alone. The AUCs ranged from 0.587 to 0.637 for the combined SRS and Twitter, from 0.525 to 0.534 for Twitter alone, and from 0.612 to 0.642 for the SRS alone. The results varied because different preprocessing procedures were applied to Twitter.

conclusionThe accuracy of signal detection using social media can be improved by combining signals with those from SRSs. However, the combined system cannot achieve better AUC performance than data from FAERS alone, which may indicate that Twitter data are not ready to be integrated into a purely data-driven combination system.

Indexed as

Adverse Drug Reaction Reporting SystemsPharmacovigilanceSocial MediaUnited States Food and Drug AdministrationHumansUnited States

Identifiers

PMID32385840
PMCPMC7434724
OpenAlexW3023985723

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.